Why the study?
Opioid overprescribing is a concern in arthroplasty, although evidence suggests surgeons can prescribe smaller quantities for postoperative pain management without compromising patient care.
Population
Patients undergoing total joint arthroplasty procedures
Design
Review
Authors
Loading...
Institutional multimodal strategies may safely reduce post-TJA opioid prescribing; leaves open optimal protocols for wider implementation.
Institutional quality improvement initiatives focusing on multimodal pain control and communication can help reduce postoperative opioid prescribing in total joint arthroplasty.
Call et al. (2025) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: